About Precision Therapeutics
Our history
Over the years, there have been many challenges in determining the best course of therapy for an individual cancer patient. The basic problem is that patients with similar diagnoses don’t always respond to the same chemotherapy, schedule, or dose. Additionally, ineffective therapies and tumors that have no established standard of care make it difficult for cancer specialists to decide upon an appropriate course of treatment. With this in mind, a group of scientists established Precision Therapeutics in 1995, with the sole aim of developing and delivering technology that could help a physician select the appropriate chemotherapy for an individual patient—giving them an edge in the fight against cancer.

Therapy as individual as the cancers themselves
Precision Therapeutics is a leader in the development of decision support tools and services that provide physicians with valuable information for the treatment of cancer patients. Our mission to improve the treatment outcomes for patients living with cancer is shaped by our strong belief that cancer patients deserve the best chance for survival. To accomplish this, we continue to develop technology that enables physicians to give patients a clear advantage by providing treatment options that are tailored to their unique cancer—as well as to its response to multiple chemotherapy options.
Image of a woman looking through a microscope

Research that leads to developments
As a leading force in research, Precision Therapeutics is committed to the development of support tools and services for individualized cancer treatment. To underscore this commitment, Precision Therapeutics has commissioned and funded multiple clinical research programs in partnership with leading medical research institutes. And we will continue to investigate methods that will facilitate the effective delivery of individualized cancer therapy—giving physicians and patients an edge in the fight against cancer.

In the lab
Precision Therapeutics’ laboratories are fully equipped to perform tissue culture-based analysis. Our laboratories have been certified to comply with the Centers for Medicare & Medicaid Services CLIA (Clinical Laboratory Improvement Amendments) program, and are licensed by the Pennsylvania Department of Health and the New York State Department of Health. Our scientific staff has extensive experience in clinical testing and cancer research and provides services to physicians throughout the United States and Canada from our headquarters in Pittsburgh, Pennsylvania.